Last update 26 Jan 2025

Pmd-1C-PEG3-1C-2C-BI

Overview

Basic Info

Drug Type
Proteolysis-targeting chimeras (PROTAC)
Synonyms
Pmd-1C-PEG3-1C-2C-BI
Target
BRAF V600E
Mechanism
BRAF V600E inhibitors
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication
BRAF V600E Mutation-Positive Melanoma
Inactive Indication-
Originator Organization
University of TorontoUniversity of Toronto
Active Organization
University of TorontoUniversity of TorontoLunenfeld-Tanenbaum Research InstituteLunenfeld-Tanenbaum Research InstituteOntario Institute for Cancer ResearchOntario Institute for Cancer Research
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC53H63F2N11O11S
InChIKeyGVOFKFUVWFBDKE-UHFFFAOYSA-N
CAS Registry-

Related

100 Clinical Results associated with Pmd-1C-PEG3-1C-2C-BI
Login to view more data
100 Translational Medicine associated with Pmd-1C-PEG3-1C-2C-BI
Login to view more data
100 Patents (Medical) associated with Pmd-1C-PEG3-1C-2C-BI
Login to view more data
100 Deals associated with Pmd-1C-PEG3-1C-2C-BI
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
BRAF V600E Mutation-Positive MelanomaPreclinical
CA
University of TorontoUniversity of Toronto
10 Aug 2020
BRAF V600E Mutation-Positive MelanomaPreclinical
CA
Lunenfeld-Tanenbaum Research InstituteLunenfeld-Tanenbaum Research Institute
10 Aug 2020
BRAF V600E Mutation-Positive MelanomaPreclinical
CA
Ontario Institute for Cancer ResearchOntario Institute for Cancer Research
10 Aug 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free